| Financial Year |
March 31 2023 |
| Monetary Funds |
41,434,524.92 |
| Held-for-trading Financial Assets |
65,400.00 |
| Notes Receivable |
6,162,416.60 |
| Accounts Receivable |
3,231,860,362.18 |
| Advances to Suppliers |
720,956,747.08 |
| Other Receivables |
402,411,494.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,203,696,833.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
90,235,847.15 |
| Total Current Assets |
6,024,082,732.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
104,850,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
10,118,552,159.21 |
| Under-construction Projects |
1,810,781,639.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
387,271,100.11 |
| R&D expenses |
4,939,744.44 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,119,478.52 |
| Deferred Income Tax Assets |
69,120,011.90 |
| Other Non-Current Assets |
230,644,488.32 |
| Sub-Total of Non-Current Assets |
12,743,857,671.98 |
| Total Assets |
18,767,940,404.97 |
| Short-Term Loans |
3,610,611,716.75 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,304,097.01 |
| Accounts Payable |
730,686,918.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
165,488,540.50 |
| Taxes Payable |
985,439,389.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
113,185,106.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,781,607,708.53 |
| Other Current Liabilities |
87,018,696.95 |
| Sub-Total of Current Liabilities |
8,044,545,449.46 |
| Long-term Loans |
-- |
| Bonds Payable |
290,571,606.39 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
19,579,640.12 |
| Deferred Income Tax Liabilities |
15,691,505.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
399,455,469.82 |
| Total Liabilities |
8,444,000,919.28 |
| Paid-In Capital(Or Share Stock) |
3,122,037,848.00 |
| Capital Surplus |
2,889,424,447.79 |
| Surplus Reserve |
243,858,247.20 |
| LESS:Treasury Stock |
67,306,270.00 |
| Undistributed Profits |
4,003,085,117.59 |
| Minority Stockholder's Interest |
52,797,238.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,271,142,247.46 |
| Owner's Equity（Stockholder's Equity） |
10,323,939,485.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,767,940,404.97 |
